Indicates confidence that burn rate not a problem as attendance at forums and sales begin to ramp. Execs have a lot of equity for pay so there's incentive there and insider activity is good. A while ago there were a lot less job openings. If they were not confident about more sales coming, they'd be conserving on the cash burn rate.
when they promote the Senior Vice President of Business Strategy and Marketing. This could mean they are happy with the stratgy and marketing results and, right now, this is what it's all about-- making a "paradigm shift in the peripheral nerve repair market". Axogen is on course to big revs. IMO!
Published on Jan 6, 2015
Jill Schiaparelli CMO (Chief Marketing Officer) of Axogen, Inc. (NASDAQ: AXGN) was Interviewed Live on 77WABC Radio "The Amilya Show" Hosted by Amilya Antonetti -- December 20, 2014
Jill Schiaparelli CMO (Chief Marketing Officer) of Axogen, Inc. (NASDAQ: AXGN) and Dr. Shahrokh C. Bagheri, Chair of Oral and Maxillofacial surgery at Northside Hospital of Atlanta were Interviewed Live on 640WGST Talk Radio Atlanta's Health Tech Talk Live Hosted by Ben Chodor -- January 10, 2015 https://www.youtube.com/watch?v=8Cbgp2sEpWQ
hey Class im with u i know have known but not to much info on this mess board. not many people follow axgn
been following for about 3 years finally got in this past summer at around $2.50 avg. got 40k this has been looking very good lately . i put an order to buy 5k today for $3.50 at 11:00 this morn. i know it closed at 3:50
late in the day but i dont know if my order filled. i use a broker this is my stock not his he bought some. this is an under valued gem if this breaks 5 dollars watch out !! and my only hope is when they sell the company it at
7 - 8 bucks. IMO there is a strong possibility this company will be sold at some point down the road. and ill be there waiting
Sentiment: Strong Buy
again and at least 5Q's in a row. But not as nice a jump as we had last Q. Would like to see better Q over Q growth but they did hit guidance of $16M for the year.
Well, they exceeded guidance of $16MM by 5%. And I will be happy if they can maintain a nice, steady 50%+ growth rate. Not sure what I think about an additional stock offering at this stock price. The Company is in a meaningfully better position than its last underwritten offering in connection with the move to NASDAQ ($3/shr I believe it was then).
This is a shelf offering. So, IMO, it won't be a big mover of the price of the stock tomorrow. I hope the investors accept that they did exceed the number promised. Also Yahoo avg. analyst estimate of $4.67M was topped , so that's real good. Hopefully we go up!!
Almost said big boys'... Axogen needs the cash backup, just in case. Announcing the intention, without date, at the time of the sales figure takes out some volatility, which is good. And stock needs hi-Q investors.. now and later... unless there is a buyout. There is a small float and it is in unusual hands. Stock and company could do very well as an independent... 50-60% growth isn't seen everyday! but got to fix the basics first.
Looks like ceiling: same pricing as last time! only that was to shake some stuff off. 20% dilution again now ... so we really need that growth. Price all the cash and debt as shares and we got 18 m new shares equivalent from around 18 previous so all told 50% of the co gone! History now though.